Peer-Reviewed Publication JOHNS HOPKINS MEDICINE FOR IMMEDIATE RELEASE Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients’ immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy. The...
Tag: <span>target</span>
Post
Scientists discover possible target for treating and preventing osteoarthritis
by University of Florida Credit: CC0 Public Domain Wear and tear on joints can lead to inflammation, breakdown of cartilage and development of osteoarthritis. Scientists at UF Scripps Biomedical Research have found a possible new target to fight this painful cascade. In a study published Thursday in the journal PLOS One, biochemist Patrick Griffin, Ph.D., and...
Post
Possible new cancer treatment target discovered
by University of Gothenburg Chandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin Lindström Researchers at the University of Gothenburg have identified a previously unknown mechanism controlling tumor growth in cultured cells and mice. This discovery may potentially enable future development of new drugs against a range...
Post
Scientists discover a target to treat fatty liver disease
by University of Southern California Credit: Pixabay/CC0 Public Domain About 80 million Americans have fatty liver disease unrelated to alcohol abuse. Nonalcoholic fatty liver disease is associated with obesity and diabetes, and can lead to more severe liver damage such as nonalcoholic steatohepatitis (NASH), cirrhosis, and liver cancer. Cardiovascular disease, colorectal cancer, and breast cancer...